Evidence-Based Reviews

Telepsychiatry: What you need to know

Author and Disclosure Information

 

References

In a review of 452 telepsychiatry studies, Hubley et al20 focused on satisfaction, reliability, treatment outcomes, implementation outcomes, cost effectiveness, and legal issues. They concluded that patients and clinicians are generally satisfied with telepsychiatry services. Interestingly, clinicians expressed more concerns about the potential adverse effects of telepsychiatry on therapeutic rapport. Hubley et al20 found no published reports of adverse events associated with telepsychiatry use.

In a study of school-based telepsychiatry in an urban setting, Mayworm et al21 found that patients were highly satisfied with both in-person and telepsychiatry services, and there were no significant differences in preference. This study also found that telepsychiatry services were more time-efficient than in-person services.

A study of using telepsychiatry to treat unipolar depression found that patient satisfaction scores improved with increasing number of video-based sessions, and were similar among all age groups.22 An analysis of this study found that total satisfaction scores were higher for patients than for clinicians.23

In a study of satisfaction with telepsychiatry among community-dwelling older veterans, 90% of participants reported liking or even preferring telepsychiatry, even though the experience was novel for most of them.24

As always, patients’ preferences need to be kept in mind when considering what services can and should be provided via telepsychiatry, because not all patients will find it acceptable. For example, in a study of veterans’ attitudes toward treatment via telepsychiatry, Goetter et al25 found that interest was mixed. Twenty-six percent of patients were “not at all comfortable,” while 13% were “extremely comfortable” using telepsychiatry from home. Notably, 33% indicated a clear preference for telepsychiatry compared to in-person mental health visits.

Continue to: Legal aspects of telepsychiatry

Pages

Recommended Reading

ACE inhibitors and severe COVID-19: Protective in older patients?
MDedge Psychiatry
COVID-19 and Mental Health Awareness Month
MDedge Psychiatry
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
MDedge Psychiatry
Neuropsychiatric manifestations of COVID-19
MDedge Psychiatry
Life during COVID-19: A pandemic of silence
MDedge Psychiatry
Telepsychiatry during COVID-19: Understanding the rules
MDedge Psychiatry
Armchair epidemiology
MDedge Psychiatry
Remdesivir shortens COVID-19 time to recovery in published study
MDedge Psychiatry
Changes in patient behavior during COVID-19: What I’ve observed
MDedge Psychiatry
Convalescent plasma: ‘Flavor of the month’ or valid COVID-19 treatment?
MDedge Psychiatry